Artivion | CRY - 债务

金融业

USD

USD 883.16M

现金及等价物

USD 55.76M

USD 42.85M

USD 357.52M

USD 92.7M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 450.47M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 215.35M

USD 873.6M

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 98M

贸易债权人

USD 18.34M

应收帐款人

USD 103.68M

	债务	更改		日
Abbott	USD 13.86B		919M	2025-12
Accuray	USD 170.24M		4.52M	2024-09
AngioDynamics	USD 6.3M		6.3M	2025-02
Artivion	USD 317.78M		619K	2024-12
AtriCure	USD 73.38M		3.35M	2025-12
Baxter International	USD 9.78B		68M	2025-12
Becton, Dickinson and Co.	USD 19.54B		358M	2025-12
Boston Scientific	USD 11.44B		610M	2025-12
Edwards Lifesciences	USD 600M		105.4M	2026-03
Inogen	USD 0		0	2022-06
Integra LifeSciences	USD 2.04B		6.27M	2026-03
J&J	USD 47.93B		2.14B	2025-12
Mesa Laboratories	USD 204.98M		7.27M	2024-09
Orthofix International	USD 137.23M		338K	2024-09
Pfizer	USD 63.73B		231M	2026-03
ResMed	USD 847.72M		1.37M	2025-12
Stryker	USD 14.22B		635M	2026-03
Tandem Diabetes Care	USD 444.48M		4.81M	2025-12
Teleflex	USD 2.73B		43.5M	2025-12
Terumo	JPY 159.87B		14.97B	2025-09
Trinity Biotech	USD 100.76M		7.05M	2024-12